诺瓦瓦克斯医药(NVAX)今日盘中大跌5.04%，成为市场关注焦点。
消息面上，美国食品和药物管理局(FDA)首席医疗和科学官维奈-普拉萨德在一份备忘录中表示，新冠疫苗接种可能导致至少10名儿童死于心脏炎症。这一消息引发了市场对疫苗安全性的担忧，导致包括诺瓦瓦克斯在内的疫苗制造商股价集体下挫。
该备忘录基于对2021年至2024年期间96例死亡病例的初步分析，虽然未明确提及涉及的疫苗生产商，但已对行业造成广泛影响。卫生部长小罗伯特-肯尼迪已要求FDA对疫苗安全性进行彻底审查，进一步加剧了市场的不确定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.